GGrantIndex
Sort

25,944 grants matching neurodegeneration

Eye Determinants of Cognition (EyeDOC) Study

$728,748
Alison G Abraham · Johns Hopkins University · R01 · FY2016 · AG

BACE1 in neurodegeneration and neurological dysfunction

$728,661
Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · R01 · FY2024 · NS

Transcriptomic and Circuitry Aberrations in Alzheimer’s Disease

$728,217
Zhen Yan · State University Of New York At Buffalo · R01 · FY2025 · AG

Evaluation of Brain and Cognitive Changes in Older Adults with MCI Taking Lithium to Prevent Alzheimer Type Dementia

$728,145
Ariel Gerard Gildengers · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AG

FEMALE REPRODUCTIVE AGING: THE ROLE OF ESTROGEN

$728,130
University Of Kentucky · P01 · FY2001 · AG

Treating primary progressive aphasia and elucidating neurodegeneration in the language network using transcranial direct current stimulation

$727,899
Roy H Hamilton · University Of Pennsylvania · R01 · FY2019 · AG

T cells in the aging brain

$727,495
Anne Brunet · Stanford University · R01 · FY2023 · AG

"What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementias

$727,449
Jonathan Graff-Radford · Mayo Clinic Rochester · R01 · FY2025 · AG

Designer Molecular Probes for Biomedical Applications

$727,444
Ivan Julian Dmochowski · University Of Pennsylvania · R35 · FY2019 · GM

Investigating the roles of RNA-binding proteins Nocte and PRRC2 in mRNA translation and age-related neurodegeneration using Drosophila and mouse models

$727,343
Weidong Wang · National Institute On Aging · ZIA · FY2025 · AG

Mitoribosome protein translation signaling and survival mechanisms

$727,340
Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2024 · AG

Mitoribosome protein translation signaling and survival mechanisms

$727,340
Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2023 · AG

Role of oligodendrocyte-derived IL-33 in brain aging and Alzheimer's disease

$727,334
Shin H Kang · Temple Univ Of The Commonwealth · R01 · FY2024 · AG

Saracatinib and 1400W Counteract Nerve Agents-induced Long-term Neurotoxicity

$727,305
Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2021 · NS

T cells in the aging brain

$726,768
Anne Brunet · Stanford University · R01 · FY2024 · AG

Clinical Core

$726,649
Lon S Schneider · University Of Southern California · P50 · FY2017 · AG

Endosome Dysfunction in Alzheimer's Disease

$726,648
Ralph A. Nixon · New York University School Of Medicine · R01 · FY2021 · AG

Validating Automated Photoreceptor Analytics Software For Degenerative Eye Disease Research and Biopharma Clinical Trials.

$726,590
Eric L. Buckland · Translational Imaging Innovations, Inc. · R44 · FY2020 · EY

Mechanisms of Mutant Prion Protein Aggregation Within Endolysosomal Pathways

$726,467
Sandra E Encalada · Scripps Research Institute, The · R01 · FY2022 · AG

Anti-viral therapy in Alzheimer's disease

$726,389
Davangere P Devanand · Columbia University Health Sciences · R01 · FY2018 · AG

Mayo Clinic Consortium for Gut Brain Communication in Parkinson's Disease

$726,298
Adil E. Bharucha · Mayo Clinic Rochester · U01 · FY2025 · DK

The Role of Impaired Neurobehavioral Alertness in Cognitive Decline and Alzheimer’s Disease Pathology

$726,189
David T Plante · University Of Wisconsin-Madison · R01 · FY2025 · AG

Retinal circuit disassembly in primate glaucoma

$726,057
Yvonne Ou · University Of California, San Francisco · R01 · FY2024 · EY

The Beaver Dam Offspring Study Neurocognitive Aging Study (BOSS-NCAS)-A Study on the Role of Accelerated Aging and Midlife Sensory Decline for Early Alzheimer’s Disease and Dementia in Later Life

$725,856
Natascha Merten · University Of Wisconsin-Madison · R01 · FY2024 · AG

Cellular and Genetic Origins of Astrocytes

$725,666
David H Rowitch · University Of California, San Francisco · R01 · FY2012 · NS